Literature DB >> 32888548

Applications of PET-MR Imaging in Cardiovascular Disorders.

Rhanderson Cardoso1, Thorsten M Leucker2.   

Abstract

Cardiac PET/MR imaging is an integrated imaging approach that requires less radiation than PET/computed tomography and combines the high spatial resolution and morphologic data from MR imaging with the physiologic information from PET. This hybrid approach has the potential to improve the diagnostic and prognostic evaluation of several cardiovascular conditions, such as ischemic heart disease, infiltrative diseases such as sarcoidosis, acute and chronic myocarditis, and cardiac masses. Herein, the authors discuss the strengths of PET and MR imaging in several cardiovascular conditions; the challenges and potential; and the current data on the application of this powerful hybrid imaging modality.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac MR imaging; Cardiac PET; Cardiac PET/MR imaging; Cardiac masses; Ischemic heart disease; Myocardial viability; Sarcoidosis

Mesh:

Year:  2020        PMID: 32888548      PMCID: PMC8323058          DOI: 10.1016/j.cpet.2020.06.007

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  76 in total

Review 1.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

Review 2.  PET/MRI of the heart.

Authors:  Christoph Rischpler; Stephan G Nekolla; Karl P Kunze; Markus Schwaiger
Journal:  Semin Nucl Med       Date:  2015-05       Impact factor: 4.446

3.  MRI-guided attenuation correction in whole-body PET/MR: assessment of the effect of bone attenuation.

Authors:  A Akbarzadeh; M R Ay; A Ahmadian; N Riahi Alam; H Zaidi
Journal:  Ann Nucl Med       Date:  2012-12-21       Impact factor: 2.668

4.  PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.

Authors:  Christoph Rischpler; Nicolas Langwieser; Michael Souvatzoglou; Anja Batrice; Sandra van Marwick; Julian Snajberk; Tareq Ibrahim; Karl-Ludwig Laugwitz; Stephan G Nekolla; Markus Schwaiger
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-02-13       Impact factor: 6.875

5.  A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.

Authors:  Anja M van der Laan; Alexander Hirsch; Lourens F H J Robbers; Robin Nijveldt; Ingrid Lommerse; Ronak Delewi; Pieter A van der Vleuten; Bart J Biemond; Jaap Jan Zwaginga; Wim J van der Giessen; Felix Zijlstra; Albert C van Rossum; Carlijn Voermans; C Ellen van der Schoot; Jan J Piek
Journal:  Am Heart J       Date:  2011-11-23       Impact factor: 4.749

6.  Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.

Authors:  Daniel S Berman; Jamshid Maddahi; B K Tamarappoo; Johannes Czernin; Raymond Taillefer; James E Udelson; C Michael Gibson; Marybeth Devine; Joel Lazewatsky; Gajanan Bhat; Dana Washburn
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

7.  Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

Authors:  Michael T Osborne; Edward A Hulten; Avinainder Singh; Alfonso H Waller; Marcio S Bittencourt; Garrick C Stewart; Jon Hainer; Venkatesh L Murthy; Hicham Skali; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2013-12-03       Impact factor: 5.952

8.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Shinji Ishimaru; Noriko Oyama; Toshiki Takei; Eriko Tsukamoto; Masatake Miura; Shinji Sakaue; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-15       Impact factor: 9.236

9.  Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading.

Authors:  Ismet Sarikaya; A H Elgazzar; M A Alfeeli; P N Sharma; A Sarikaya
Journal:  J Saudi Heart Assoc       Date:  2017-07-10

Review 10.  MR/PET Imaging of the Cardiovascular System.

Authors:  Philip M Robson; Damini Dey; David E Newby; Daniel Berman; Debiao Li; Zahi A Fayad; Marc R Dweck
Journal:  JACC Cardiovasc Imaging       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.